A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors

NCT06508307 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
Cervical Cancer
Colon Cancer
Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Breast Cancer
Gastric Cancer

Interventions

BIOLOGICAL: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patients With Advanced Solid Tumors

Sponsor

GONGCHU Biotechnology Co., Ltd